ROYAL BANK OF CANADA - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 30 filers reported holding CANCER GENETICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2019$4,0000.0%35,000
+45.8%
0.00%
Q2 2019$4,000
-50.0%
24,000
-29.4%
0.00%
Q1 2019$8,00034,000
+377677.8%
0.00%
Q4 2017$0
-100.0%
9
-98.9%
0.00%
Q3 2017$2,000
-90.5%
809
-84.7%
0.00%
Q2 2017$21,000
-4.5%
5,276
-1.3%
0.00%
Q1 2017$22,0005,344
+5409.3%
0.00%
Q2 2016$097
+273.1%
0.00%
Q3 2015$0260.0%0.00%
Q2 2015$0
-100.0%
26
-99.0%
0.00%
Q1 2015$20,000
+1900.0%
2,500
+5002.0%
0.00%
Q2 2014$1,000
-90.0%
49
-93.5%
0.00%
Q4 2013$10,0007500.00%
Other shareholders
CANCER GENETICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
DOMINI IMPACT INVESTMENTS LLC 30,048$235,0003.84%
Millrace Asset Group, Inc. 198,774$1,554,0001.67%
EAM Investors, LLC 129,972$1,016,0000.16%
TURNER INVESTMENTS LLC 94,730$741,0000.15%
Granite Investment Partners, LLC 156,993$1,227,0000.12%
Sterneck Capital Management, LLC 20,030$157,0000.10%
DIKER MANAGEMENT LLC 28,815$225,0000.05%
ARDSLEY ADVISORY PARTNERS LP 15,000$117,0000.03%
VANGUARD GROUP INC 4,972,880$172,109,0000.01%
DENVER INVESTMENT ADVISORS LLC 14,141$111,0000.01%
View complete list of CANCER GENETICS INC shareholders